α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses ; volume:13 ; number:1 ; day:26 ; month:8 ; year:2016 ; pages:1-7 ; date:12.2016
Journal of neuroinflammation ; 13, Heft 1 (26.8.2016), 1-7, 12.2016
- Creator
-
Ettle, Benjamin
- Contributor
-
Kuhbandner, Kristina
Jörg, Stefanie
Hoffmann, Alana
Winkler, Jürgen
Linker, Ralf A.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-016-0694-4
- URN
-
urn:nbn:de:1111-201609248597
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ettle, Benjamin
- Kuhbandner, Kristina
- Jörg, Stefanie
- Hoffmann, Alana
- Winkler, Jürgen
- Linker, Ralf A.
- SpringerLink (Online service)
Other Objects (12)
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Expression des CEA im ersten Trimenon der Schwangerschaft
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Distinct neuroinflammatory pattern in multiple system atrophy
Generation and characterization of human oligodendroglia as cellular model for Multiple System Atrophy
Compensatory mechanisms and therapeutic approaches in neuronal protein aggregation disorders
Modeling neurodevelopment and cortical dysfunction in SPG11-linked hereditary spastic paraplegia using human induced pluripotent stem cells
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Expression des CEA im ersten Trimenon der Schwangerschaft
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Distinct neuroinflammatory pattern in multiple system atrophy
Generation and characterization of human oligodendroglia as cellular model for Multiple System Atrophy
Compensatory mechanisms and therapeutic approaches in neuronal protein aggregation disorders
Modeling neurodevelopment and cortical dysfunction in SPG11-linked hereditary spastic paraplegia using human induced pluripotent stem cells
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Expression des CEA im ersten Trimenon der Schwangerschaft
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Distinct neuroinflammatory pattern in multiple system atrophy
Generation and characterization of human oligodendroglia as cellular model for Multiple System Atrophy
Compensatory mechanisms and therapeutic approaches in neuronal protein aggregation disorders